KARACHI, July 15 -- In a landmark achievement for Pakistan's health and science sector, Dow University of Health Sciences (DUHS) has successfully developed the country's first-ever indigenous biomolecule for the production of a human anti-rabies vaccine. The development is being hailed as a critical step toward reducing the country's reliance on expensive imported vaccines.
Each year, between 2,000 to 5,000 people in Pakistan die of rabies, largely from dog bites. The country imports all its anti-rabies vaccines, costing Rs26 billion annually, a burden expected to rise to Rs100 billion by 2031 when global aid from GAVI, UNICEF, and WHO ends. With millions of doses needed yearly, this indigenous breakthrough could provide long-term, cost-...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.